Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

This study was an open, single center, prospective cohort study design. Subjects with advanced gastric cancer who had received first-line chemotherapy (cohort 1) and systematic chemotherapy combined with immunotherapy (cohort 2) were included in this study. 20 cases were included in each population, and a total of 40 subjects were planned to be included.

Participants needed: 40
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong Tumor HospitalUpdated: Mar 13, 2026Locations: 1
Eligibility criteria

Age range: 18 to 75 years old, both male and female are acceptable; [+9]

History of gastrointestinal perforation and/or fistula within 6 months prior to... [+22]

Read more
Status: Recruiting

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

This study employs a randomized, controlled, exploratory clinical trial design, with a planned enrollment of 66 patients who have previously failed systemic chemotherapy for recurrent/metastatic gastric cancer,

Participants needed: 66
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong Tumor HospitalUpdated: Dec 30, 2025Locations: 1
Eligibility criteria

1. Patients with advanced gastric adenocarcinoma or gastroesophageal junction ad... [+7]

1. History of gastrointestinal perforation and/or fistula within 6 months prior... [+20]

Read more
Status: Not yet recruiting

Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer

The primary objective of this study is to evaluate the efficacy and safety of Iparomlimab and tuvonralimab (QL1706) in combination with platinum-based chemotherapy for cervical cancer neoadjuvant therapy. Additionally, the study aims to identify potential predictive biomarkers for therapeutic efficacy by analyzing tumor tissues and peripheral blood samples from participants receiving this combined treatment regimen.

Participants needed: 28
Trial details
Phase: Phase 2Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Shandong Tumor HospitalUpdated: May 22, 2025
Eligibility criteria

Voluntary signing of written Informed Consent Form (ICF). [+11]

Histopathological type other than cervical squamous cell carcinoma, adenocarcino... [+20]

Read more